Volume 7, Issue 5, September 2019, Page: 118-123
Primary Idiopathic Chylopericardium as Unusual Cause of Cardiac Tamponade
Gabriel Aranalde, Division of Internal Medicine, Emergency Hospital “Dr. Clemente Alvarez”, Santa Fe, Argentina; Department of Human Physiology, National University of Rosario, Santa Fe, Argentina
Román Martinez Lorenzin, Division of Internal Medicine, Emergency Hospital “Dr. Clemente Alvarez”, Santa Fe, Argentina
Martín Cánaves, Division of Cardiology, Emergency Hospital “Dr. Clemente Alvarez”, Santa Fe, Argentina
Cielo Gomez, Division of Internal Medicine, Emergency Hospital “Dr. Clemente Alvarez”, Santa Fe, Argentina
Domingo Cera, Division of Internal Medicine, Emergency Hospital “Dr. Clemente Alvarez”, Santa Fe, Argentina
Received: Jul. 23, 2019;       Accepted: Aug. 21, 2019;       Published: Sep. 4, 2019
DOI: 10.11648/j.ajim.20190705.12      View  23      Downloads  14
Abstract
The chylopericardium is defined as the accumulation of chylous fluid containing high concentrations of triglycerides in the pericardial space. It is quite an uncommon condition first described in 1888 by Hasebroek. The absence of an underlying etiology defines it as primary idiopathic chylopericardium, term initially used in a study by Groves and Effler in 1954. Even when most patients are asymptomatic, constrictive pericarditis or cardiac tamponade may be referred. Cardiac tamponade, the most serious complication, represents an entity characterized by fluid accumulation in the pericardial cavity. Claudius Galen from Pergamum (131-201 D. C.) described pericardial effusions in gladiators with stab injuries of the chest and Richard Lowe (1669) described its physiology. It took two hundred years for the term "cardiac tamponade" was coined by german surgeon Edmund Rose. Cardiac tamponade can be presented from asymptomatic setting to life-threatening conditions. By the former reason, the early recognition of this entity has crucial importance. Idiopathic chylopericardium occurs in all age groups and affects both sexes equally. Although several mechanisms have been proposed in order to explain the development of chylopericardium, the underlying pathophysiology remains unclear. Damaged lymphatic vessels with abnormal communication of the thoracic duct to the pericardial lymphatics and elevated pressure in the thoracic duct can justify the presence of chyle into the pericardial sac. Diagnosis is confirmed by pericardiocentesis which must reveal at least two of the classical five criteria. Chylopericardium may be managed through conservative or surgical treatment. The conservative treatment consist a medium chain triglyceride diet or total parenteral nutrition but has a high degree of recurrence, for which reason the safest option is thoracic duct ligation with a pericardial window. The present study reports a case of chylopericardium wherein the leak was diagnosed by lymphoscintigraphy that was successfully treated by a low-fat diet, rich in medium-chain triglycerides and octreotide infusion.
Keywords
Chylopericardium, Cardiac Tamponade, Lymphangiography, Pericardiocentesis
To cite this article
Gabriel Aranalde, Román Martinez Lorenzin, Martín Cánaves, Cielo Gomez, Domingo Cera, Primary Idiopathic Chylopericardium as Unusual Cause of Cardiac Tamponade, American Journal of Internal Medicine. Vol. 7, No. 5, 2019, pp. 118-123. doi: 10.11648/j.ajim.20190705.12
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Yu et al. Primary chylopericardium: A case report and literature review. Experimental and Therapeutic Medicine. 2018; 15: 419-425.
[2]
Öztürk S, Durmuş G, Ağuş HZ, Koç A, Can MM. A rare cause of pericardial tamponade: Chylopericardium. Anatol J Cardiol. 2017; 18 (6): E11-E12.
[3]
Livesay J, Biney I, Turner Jr. JF. Chylothorax and Chylopericardium: A Complication of Long-Term Central Venous Catheter Use. Case Rep Pulmonol. 2019; 11: 1-5.
[4]
Di Liso E et al. Neoplastic Pericardial Effusion: A Monocentric Retrospective Study. Journal of Palliative Medicine 2019; 22 (6): 691-695.
[5]
McNamara N, Ibrahim A, Satti Z, Ibrahim M, Kiernan TJ. Acute pericarditis: a review of current diagnostic and management guidelines. Future Cardiol. 2019; 15 (2): 119-126.
[6]
Lara K, Reber J, DuBrock H, Araoz P, Lin G. Chylopericardium secondary to thoracic duct obstruction in a patient with plastic bronchitis. Journal of the American College of Cardiology 2019; 73 (9) S1.
[7]
Barbetakis N, Asteriou C, Konstantinou D, Giannoglou D, Tsilikas C, Giannoglou G. Spontaneous chylous cardiac tamponade: a case report. Journal of Cardiothoracic Surgery 2010; 5: 11-16.
[8]
Malhotra G, Chick JFB, Srinivasa RN, Hussain JS, Gemmete JJ, Srinivasa RN. Mediastinal Lymphangioma Complicated by Chylopericardium, Tamponade, and Cardiac Arrest Treated with an Endolymphatic Stent Graft. J Vasc Interv Radiol. 2018; 29 (10): 1438-1439.
[9]
Sasaki A, Watanabe Y, Tokunaga C. Chylopericardium following mitral valve replacement. Jpn J Thorac Cardiovasc Surg 2002; 50: 518-9.
[10]
Mogulkoc N, Onal B, Okyay N, Gunel O, Bayindir U. Chylothorax, chylopericardium and lymphoedema-the presenting features of signet-ring cell carcinoma. Eur Respir J 1999; 13: 1489-91.
[11]
Fernandes F, Arteaga E, Carvalho MSS, Ianni BM, Fernandes PP, Mady C. Quilopericardio idiopático. Arq Bras Cardiol 1998; 71: 131-4.
[12]
Dib C, Tajik AJ, Park S, Kheir ME, Khandieria B, Mookadam F. Chylopericardium in adults: A literature review over the past decade (1996–2006). J Thorac Cardiovasc Surg 2008; 196: 650-6.
[13]
Swelstad MR, Frumiento C, Garry-McCoy A, Agni R, Weigel TL. Chylotamponade: an unusual presentation of Gorham’s syndrome. Ann Thorac Surg. 2003; 75: 1650-2.
[14]
Dunn RP. Primary chylopericardium, a review of the literatura and an illustrated case. Am Heart J 1975; 79: 369-77.
[15]
Cho BC, Kang SM, Lee SC, Moon JG, Lee DH, Lim SH. Primary idiopathic chylopericardium associated with cervicomediastinal cystic hygroma. Yonsei Med J 2005; 46: 439-44.
[16]
Han Z, Li S, Jing H, Liu H. Primary idiopathic chylopericardium: a retrospective case series. BMC Surg 2015; 15: 61-5.
[17]
Silva MA, Martins AS, Campos NL, Andrade RR, Tohi LM, Hueb JC. Primary Idiopathic Chylopericardium - Case Report. Arq Bras Cardiol 2009; 92: e40-e43.
[18]
Groves LK, Effler DB. Primary chylopericardium. N Engl J Med 1954; 250: 520-3.
[19]
Hasebroeck K. Analyse einer chylosen pericardierlen Flussigkeit (chylopericardium). Ztschr Physiol Chemie 1888; 12: 289.
[20]
Svedjeholm R, Jansson K, Olin C. Primary idiopathic chylopericardium-a case report and review of the literature. Eur J Cardiothorac Surg 1997; 11: 387-90.
[21]
Mehrotra S, Peeran NA, Bandyopadhyay A. Idiopathic chylopericardium: an unusual cause of cardiac tamponade. Tex Heart Inst J 2006; 33: 249-52.
[22]
Jasani M, Shah A, Shah AV. Pediatric Chylopericardium: Treatment Conundrum. J Indian Assoc Pediatr Surg. 2018; 23 (1): 51-52.
[23]
Alsmady M. Chylopericardium presenting as cardiac tamponade secondary to mediastinal lymphangioma. Ann R Coll Surg Engl 2016; 98: e154-e156.
[24]
Montañez-Valverde R, Olarte N, Zablah G, Hurtado de Mendoza D, Colombo R. Swinging heart caused by diffuse large B-cell lymphoma. Oxford Medical Case Reports, 2018; 9, 299–301.
[25]
Mask WK, Penido JR, Printup C. Primary idiopathic chylopericardium. J Thorac Cardiovasc Surg 1990; 99: 569-71.
[26]
Nanjo S, Yamazaki J, Tsubuku M, Ohyama T, Ohtsuka T, Nakano H. Primary idiopathic chylopericardium: report of two cases. Ann Nucl Med 2004; 18: 537-9.
[27]
Hsu CY, Huang LY, Chan JS, Yang CC, Hsiao PJ. Chylopericardium. QJM. 2018 Mar 1; 111 (3): 203-204.
[28]
Scholten C, Staudacher M, Girsch W, Wolf G, Grimm M, Binder T, et al. A novel therapeutic strategy for the management of idiopathic chylopericardium and chylothorax. Surgery 1998; 123: 369-70.
[29]
Morishita Y, Taira A, Furoi A, Arima S, Tanaka H. Constrictive pericarditis secondary to primary chylopericardium. Am Heart J 1985; 109: 373-5.
[30]
Qureshy A, Kubota K, Ono S, Sato T, Fukuda H. Thoracic duct scintigraphy by orally administered I-123 BMIPP: normal findings and a case report. Clin Nucl Med 2001; 26: 847-55.
[31]
Namba N et al. Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis. Intern Med 2017: 56: 3327-3331.
[32]
Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment. J Clin Transl Hepatol. 2018 Mar 28; 6 (1): 105-113.
[33]
Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther. 2017; 46: 816-824.
[34]
Hattori H, Dakeshita E, Nakazato J et al. Primary chylopericardium treated by surgery: Report of two cases. J Cardiol Cases 2011; 3: e106-e110.
[35]
Wurnig PN, Hollaus PH, Ohtsuka T, Flege JB, Wolf RK. Thoracoscopic direct clipping of the thoracic duct for chylopericardium and chylothorax. Ann Thorac Surg 2000; 70: 1662-5.
[36]
Selle JG, Snyder WH 3rd, Schreiber JT. Chylothorax: indications for surgery. Ann Surg 1973; 177: 245-9.
[37]
Kannagi T, Osakada G, Wakabayashi A, Kawai C, Matsuda M, Miki S. Primary chylopericardium. Chest 1982; 81: 105-108.
[38]
Lampson RS. Traumatic chylothorax, a review of the literature and report of a case treated by mediastinal ligation of the thoracic duct. J Thorac Surg 1948; 17: 778-91.
Browse journals by subject